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ABSTRACT At the ganglionic nicotinic acetylcholine channel (Gurney, A. M., and H. P. Rang, 1984, Br. J.
Pharmacol., 82:623-642) and on some cholinergic neuromuscular synapses of Crustacea (Lingle, C., 1983a, J. Physiol.
(Lond.), 339:395-417; Lingle, C., 1983b, J. Physiol. (Lond.), 339:419-437), some agents that block cholinergic currents
by an open-channel block mechanism appear to become trapped within the channel when it subsequently closes. It is
unknown whether trapping of some open-channel blockers might also occur at the neuromuscular nicotinic acetylcho-
line channel. Here we show that the long-lived cholinergic blocking action of chlorisondamine, a ganglionic nicotinic
blocker, can in part be most simply explained by an open-channel block mechanism followed by a subsequent trapping
of the blocking molecule within the closed ion channel. Unique structural characteristics of the chlorisondamine
molecule place several provocative constraints on the mechanism by which trapping may be occurring.
INTRODUCTION
The study of membrane currents and their modification by
particular drugs continues to provide valuable information
about the functional architecture of ion channels, which
might otherwise be rather inaccessible to direct structural
methods (Miller, 1982). For example, pharmacological
agents have proven useful in providing estimates of the
minimum diameter of channel permeation pathways
(Dwyer et al., 1980) and in the elucidation of molecular
changes that may be associated with channel gating and
inactivation (Armstrong, 1971). One type of channel block
phenomenon that any model of ion channel structure must
account for is the apparent occurrence of trapping (Arm-
strong, 1971) of particular channel blockers within the
closed channel. Until recently, trapping of molecules
within channels had been observed exclusively in the
sodium (Hille, 1977) and potassium (Armstrong, 1971)
channels of squid axon and appeared to be restricted
primarily to quaternary ammonium compounds of a rather
lipophilic nature. More recently, trapping of much simpler
diquaternary ammonium compounds of various chain
lengths (Gurney and Rang, 1984) and of secondary,
tertiary, and quaternary amines (Lingle, 1983a, b) in
different nicotinic cholinergic channels has been reported.
As yet it is unclear to what extent trapping of molecules
may be a general feature of ion channels. Clearly, in cases
where it has been examined, trapping is likely to occur with
only a small fraction of all channel closures. However, the
existence of any trapping at all certainly has powerful
implications for models of channel architecture. Neverthe-
less, trapping has received substantially less consideration
than the ultimately less informative type of blockade in
which blocker is transiently associated solely with the open
conformation of the ion channel protein.
Here we present evidence that at the frog neuromuscular
junction, chlorisondamine, in addition to acting as an
open-channel blocker, leads to a stable blocked state that
can only be unblocked by subsequent addition of agonist.
The existence of a very long-lasting, perhaps irreversible
component of blockade is also discussed. A preliminary
account of this report has been presented (Neely and
Lingle, 1985).
METHODS
All experiments were performed on the cutaneous pectoris of Rana
pipiens, which were obtained from Charles 0. Sullivan Co., Nashville,
TN. Conventional two-microelectrode voltage-clamp with a virtual
ground current monitor was used to record spontaneous miniature end
plate currents (MEPCs) and currents induced by iontophoretic applica-
tion of acetylcholine (ACh). Recording microelectrodes were filled with 4
M potassium acetate/0.5 KCI (<10 MO) and iontophoretic electrodes
with 1 M ACh (>60 MQl). A braking current of 10-15 nA was routinely
applied to the iontophoretic electrode to minimize leakage of ACh from
the pipette. Duration, intensity, and the frequency of pulses of ACh were
adjusted carefully to obtain cholinergic currents of constant amplitude.
Additionally, the iontophoretic electrode was positioned such that a fast
rising phase in the agonist-induced current was obtained, while at the
same time minimal desensitization during a series of agonist pulses was
observed. For selection of impalements, the rise time of the MEPCs and
the quality of clamping of the MEPC current were used as the primary
criteria after fine nerve branches had been visualized under the dissecting
microscope (model M5A, x 100, Wild Heerbrugg Ltd, Heerbrugg,
Switzerland). For recording of MEPCs, the saline contained the follow-
ing: 110 mM NaCl, 5 mM KCI, 2 mM CaCl2, 2 mM MgCl2, 1.15 mM
maleic acid, 2.50 mM Tris, pH 7.3 with 10 nM tetrodotoxin (TTX) to
prevent contraction. In iontophoretic experiments, 4 mM MnCI2 was
added to the saline to increase input resistance and improve space clamp
conditions. MEPCs were digitized and captured on line by a microcom-
puter using a single-level threshold criteria. Averaging of MEPCs was
performed off line to optimize alignment of MEPC rising phases.
Alignment was accomplished using a matchfilter algorithm. MEPC
decay times were obtained by a nonlinear least-squares fitting routine
based on the RMSSQ subroutine from the International Math and
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Statistics Library, Bellaire, TX, in which the amplitude oft
component, the exponential decay time constant, and
independently adjusted. Preparations were continuously
saline at -10 ml/min with a bath volume of 2-3 ml. Applic
and exchanges of solutions were accomplished by solen
switches in the perfusion lines. All experiments were
temperature (22-250C). Acetylcholine and TTX were
Sigma Chemical Co., St. Louis, MO and chlorisondamine
gift from Ciba Pharmaceutical Co., Summit, NJ.
RESULTS
Effects on lontophoretic Currents
The basic qualitative features of blockade ar
from chlorisondamine action on cholinergic cur
frog end plate are summarized in Fig. 1. Thr
aspects of chlorisondamine action can be discei
the context of simple iontophoretic applicatio
First, virtually no blockade of cholinergic curr
until agonist application is initiated, which su
blockade by chlorisondamine reflects an actior
of the channel occurring subsequent to the op
tion. Second, once blockade is initiated, the ap
steady-state level of block occurs quite slowly.
washout of chlorisondamine, recovery is very s
some extent, irreversible.
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FIGURE I Qualitative features of blockade by chlorisond,
phoretic currents activated by acetylcholine at the frog end
currents were activated by repetitive pulses of acetylchol
10-s intervals to minimize desensitization between pul
correspond to the same muscle fiber voltage-clamped
Record B starts after a recovery period of 500 s following
10-7 M chlorisondamine was introduced into the perft
washed out as indicated by the arrows. During introducti(
the preparation, agonist application was suspended. In A, a
tion was reinitiated -80 s after drug application, while
elapsed prior to agonist application. In A the first respons
15% relative to the control response, while in B the first
reduced 18% relative to the control. The slow developme
once agonist application is initiated and the slow recovery f
damine action are also illustrated. Vertical calibration, 10
tal calibration, 100 s.
'he exponential In the experiment illustrated in Fig. 1, after a stablebaseline were control amplitude was maintained for a period of at least 2
nfused dith min in normal saline, a solution containing 0.5,u M chlori-
oid-controlled sondamine was perfused over the preparation. To test for
done at room the existence of an agonist-independent component of
obtained from blockade, the drug-containing saline was allowed to fully
chloride was a exchange and bathe the preparation for 2 min before any
agonist was applied. When agonist application was subse-
quently initiated, the response to the first iontophoretic
pulse in the presence of drug showed a 15% blockade.
When the same sequence was repeated in the same cell
id recovery with a somewhat longer interval before the first agonist
,rents at the pulse, the first agonist pulse was blocked 18% (Fig.1 B).
ee primary These results indicate that little or no blockade of the ACh
rned within response occurs until agonist application is initiated asIns of ACh. expected for an open-channel blocker. Given additional
,ents occurs evidence presented below that chlorisondamine blocks the
Lggests that open-state of the ACh channel, it is likely that the small
n on a state component of blockade observed during the first agonist
oening reac- pulse reflects blockade of agonist-opened ion channels
iproach to a during the rising phase of the cholinergic current.
Third, after Although we can not rigorously exclude the possibility that
low and, to a small component of block may occur either at the ACh
receptor site or by a direct action on the closed channel,
such effects, if they occur, are clearly secondary to the
CH3 c 3 main effect of chlorisondamine under consideration here.MNCH2CHI2NCH3 Fig. 1 also shows the slow onset of blockade in thei CH3 presence of chlorisondamine. That this slowly developing
block reflects an action on the opened ion channel is
indicated by a comparison of Fig. 1, A and B. In Fig. 1 A
the slowly developing block results in a >75% reduction in
m¶TJTfTJT the amplitude of the cholinergic currents. In Fig1 B after a
similar period of time during which agonist was not
applied, blockade remains undeveloped. This indicates that
exposure to agonist is required for the slow blockade to
develop and is consistent with the action of an open-
channel blocker with a slow dissociation rate (Adams and
Feltz, 1980; Colquhoun, Dreyer, and Sheridan, 1979).
Finally, Fig. 1 illustrates some qualitative features of711T1T unblocking from chlorisondamine action. After the short
series of ACh pulses produced a significant level of block-
ade, agonist application was suspended for -1 min. The
I-plate. Inward amount of recovery revealed by the subsequent response to
line applied at an ACh pulse is minimal, even after washout of the drug
Ises. A and B and a longer recovery time (Fig. 1 B). When the agonist
at -100 mV. pulses are maintained during washout, a multiplicity of
record A. 5 x components in the recovery kinetics becomes apparent.
usion line and However, even after an extensive period of wash (500 s)gonist applica- separating the records in Fig. 1, A and B, the response (Fig.
in B I200s 1 B) only reaches 80% of the amplitude attained before these was reduced cell has been exposed to chlorisondamine (Fig. 1 A). We
response was have been unable to identify conditions that lead to full
nt of blockade recovery of these blocked channels whether by voltage
o nAm hlorizon- steps or by agonist application, although this point will be
considered further below.
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Blockade of MEPCS
Further evidence that the blocking action of chlorisondam-
ine involves a direct action on the open form of the ACh
channel is provided by the effect of chlorisondamine on the
decay time of MEPCs (Fig. 2). In controls, a typical single
exponential decay with a time constant that increased with
hyperpolarization was observed. In the presence of chlori-
sondamine, MEPCs can also be fit by single exponential
functions but with faster time constants. The shortening of
the decay increases steeply with hyperpolarization (Fig. 2
B), revealing a strong voltage dependence of the action of
chlorisondamine.
During application of chlorisondamine, a gradual reduc-
tion in mean MEPC amplitude was also observed. This is
consistent with the idea suggested above that, although
only a small fraction of opened channels may become
blocked during any individual MEPC, recovery from that
blockade is quite slow. This is also supported by the
absence of any significant slow component in the MEPC
decay. In accordance with the standard sequential blocking
model, the absence of a slow component suggests that the
processes leading to unblocking are much slower than the
time course of the synaptic current. As such, the rate of
decay of the MEPCs would be expected to comply with the
following relationship:
r-' = a + f [chlorisondamine], (1)
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where a represents the apparent rate of channel closure
and f is the forward rate of blockade. Consistent with this
idea that blockade by chlorisondamine results from a
pseudo-first-order blocking reaction, the MEPC decay
rate exhibited an approximately linear dependence on
chlorisondamine concentration with a forward rate of 1.9
x 108 M-' s-' at -140 mV (Fig. 3 A). In Fig. 3 B, the
forward rate of block is plotted as a function of membrane
potential and exhibits an approximately e-fold increase per
30 mV hyperpolarization. These features of the action of
chlorisondamine are consistent with a simple channel block
mechanism in which rates of unblocking are slow. The
large voltage dependence of the forward blocking rate
perhaps reflects the relatively close juxtaposition of two
quaternary ammonium groups in the chlorisondamine
molecule, both of which may sense the electric field of the
membrane.
Agonist-dependent Recovery from
Chlorisondamine Blockade
The experiments illustrated in Fig. 4 were designed to
examine aspects of unblocking from chlorisondamine. The
muscle cell membrane potential was stepped between two
voltages (- 45 mV and -1I15 mV in Fig. 4 A; - 60 mV and
-115 mV in Fig. 4 B) while cholinergic currents were
elicited by iontophoretic application of acetylcholine in the
.. .*
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FIGURE 2 Effect of chlorisondamine on spontaneous miniature synaptic currents. (A) Left, averages of MEPCs in normal saline obtained at
the indicated membrane potentials are illustrated. Right, averages of MEPCs after application of 8 ,uM chlorisondamine are shown. Each
trace corresponds to the average of at least 30 individual MEPCs. Points correspond to the digitized raw data and lines are single exponential
fits to the experimental data. Holding potentials are indicated on each trace and time constants are as follows: controls from top to bottom,
1.40, 1.60, 2.43, and 2.91 ms; 8 MM chlorisondamine from top to bottom, 1.66, 1.51, 1.13 and 1.30 ms. Vertical calibration, 1.0 nA; horizontal
calibration, 4.8 ms. (B) The MEPC decay time constant is plotted as a function of membrane voltage both in the presence (filled triangles)
and absence (filled circles) of 8 x 10-6 M chlorisondamine. Data were obtained from a single cell. The line over control points was a
least-squares fit with a slope of 103 mV/e-fold change in MEPC decay time while the line over points obtained in chlorisondamine was drawn
by eye.
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FIGURE 3 Concentration-dependence of shortening of MEPC decay times. (A) the MEPC decay rate is plotted as a function of
chlorisondamine concentration for three different membrane voltages with all data obtained from one cell. The points at each voltage were fit
by linear regression and the slope of the lines were 1.7 x 107 M ' s' at -64 mV, 7.5 x 107M -' s' at -100 mV, and 1.9 x 10' M ''s' at
-140 mV. Over this concentration range no indication of saturation in decay (ate with concentration was observed. (B) The forward blocking
rate constants obtained from the slopes of the lines in A are plotted as a function of membrane potential. The forward blocking rate varies
approximately e-fold for a 30-mV change in membrane potential.
A
B -60mV
- 115 mV
L
FIGURE 4 Agonist-dependent recovery from blockade by chlorisondam-
ine. (A) The muscle cell membrane potential was stepped between -45
and - 1 15 mV and acetylcholine was applied iontophoretically to activate
inward currents while the preparation was continuously exposed to 5 x
I0-7 M chlorisondamine. After development of blockade at -115 mV, a
recovery period at -45 mV, during which agonist was not applied, results
in no recovery in sensitivity to acetylcholine. After a recovery period at
-45 mV in which two pulses of acetylcholine were applied, a substantial
recovery in the response at -115 mV was observed. (B) An experiment
similar to that shown in A is illustrated except that the cell was stepped
between -60 and -115 mV. In addition, the time of initial application of
acetylcholine following return steps to -115 mV was kept strictly fixed.
Again, a component of blocked channels requires reactivation by agonist
to produce recovery. In both A and B the capacitative transients that
occur at the time of a voltage-step have been truncated for clarity.
Vertical calibration, 50 nA for both A and B; horizontal calibration, 5 s in
Aand 10sinB.
presence of 0.5 ,uM chlorisondamine. At least in part
because of the strong voltage dependence of the forward
blocking rate, a marked difference in the blocking equilib-
rium between the two potentials is observed. At this rather
low concentration of chlorisondamine, at the more positive
membrane potentials only a slight blockade was observed.
After a hyperpolarizing step, further blockade slowly
develops. A step back to a less depolarized level in the
absence of agonist application fails to produce recovery in
the cholinergic current after return to the more negative
potential. In contrast, agonist application when the cell is
held at the less hyperpolarized level results in a substantial
recovery in the amplitude of the cholinergic current after
return to the more negative potential.
The above result indicates that a significant portion of
blocked channels enters some state that prevents the
unbinding of the blocker from the channel irrespective of
the membrane potential of the cell. Recovery from that
blocked state requires subsequent exposure of the channels
to agonist. Exposure of acetylcholine channels to agonist is
thought to directly lead to at least two different types of
functional states: open or ion-conducting states and desen-
sitized states. Thus, the agonist dependence of the develop-
ment of blockade by chlorisondamine could conceiveably
result from a preferential affinity for either of these types
of states. However, in addition to the agonist dependence of
blockade, chlorisondamine exhibits an agonist-dependent
recovery. If the effect of chlorisondamine were to stabilize
the desensitized state, further application of agonist would
only be expected to increase the number of channels in that
nonconducting state. Alternatively, if chlorisondamine
binds specifically to the open state, which subsequently
undergoes closure, such a closed-blocked state would be
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expected to be reversed by the application of agonist as is
observed. The simplest scheme (Lingle, 1983a) that quali-
tatively accounts for these phenomena is therefore the
following:
ka ~~~~f[BJ2ACh + R ACh2R ACh2R* _
kd a b
kd
ACh2R*B RB + 2ACh. (2)
This model, although related to previously described
cyclic schemes (eg., Adams, 1977; and Gurney and Rang,
1984) suggests that the channel can close while blocked
but that neither blockade of the closed channel nor
unblocking of the blocked-closed channel can occur. Thus,
the presence of the blocking molecule in its blocking site
does not completely hinder the gating of the channel and
the drug binding site is only accessible when the gate is
open.
The above model does not explain the irreversible com-
ponent of the blocking action of chlorisondamine at the
frog end-plate, which we consistently observe. This irre-
versibility has compromised our attempts to quantitatively
characterize the recovery from blockade by chlorisondam-
ine and we have little information about the irreversible
processes. We have noted, using iontophoretic experi-
ments, that the extent of irreversibility was correlated with
the length of time that channels were allowed to remain in
the blocked-closed state without reactivation. Repeated
activation of channels in the presence of chlorisondamine
appeared to minimize the slow irreversible degradation in
cholinergic sensitivity. This would argue against the possi-
bility that the irreversible component of chlorisondamine
action is unrelated to the other phenomena described
above. Rather, these observations would suggest that a
blocked-closed channel can undergo some subsequent tran-
sition to a state exceedingly refractory to subsequent
activation and unblocking. In this scheme, a channel would
be protected from this state by reactivation and unblock-
ing.
DISCUSSION
The vertebrate end-plate ACh channel has been the sub-
ject of extensive pharmacological characterization, and a
wide variety of molecules appear to occlude the ion perme-
ation pathway after channel opening. It is perhaps surpris-
ing that, to our knowledge, this is the first explicit demon-
stration that any blocker may become trapped in the closed
neuromuscular ACh channel, although trapping has been
proposed and discarded as a possible mechanism of desen-
sitization (Adams, 1975) and as an explanation for some
aspects of blockade by procaine (Gage and Wachtel,
1984). However, without the use of experimental protocols
similar to those of Fig. 4 (Gurney and Rang, 1984; Lingle,
1983a, b), an agonist-dependent component of recovery
from blockade may easily go undetected. Even with such
protocols, if both the dissociation rate of the blocker from
its binding site is rapid and the reopening for the blocked-
closed channel is not too dissimilar from the normal
opening rate, the existence of the blocked-closed state
would be unobserved.
Is there evidence that other agents may be trapped in
neuromuscular ACh channels? For a phenomenon that
may occur in only a small fraction of all channel blocking
events, the usual kinetic tests of channel blocking mecha-
nisms would, in general, be inadequate (eg., Adams and
Sakmann, 1978; Adams and Feltz, 1980). One type of
observation is at least suggestive that with some agents
trapping may occur. For blockers with rapid unblocking
rates, the simple channel block model predicts that, as
blocker concentration is increased, the duration of the
bursts of openings should increase linearly with blocker
concentration. Recently, bursts of single channel openings
produced in the presence of either QX-222 (Neher, 1983)
or mecamylamine (Varanda et al., 1985) have been shown
to be shorter than would be predicted by a simple channel
block scheme. This effect on burst length, although consis-
tent with any mechanism in which the channel can enter
long-lived closed states, could be explained by trapping.
This action of mecamylamine is of particular interest, since
mecamylamine clearly results in the trapping phenomenon
at the crustacean acetylcholine channel (Lingle, 1983b).
The possibility of closure of blocked-open channels has also
been suggested as an explanation for some aspects of the
blockade by barbiturates of the ACh-activated sodium
channels in Aplysia (Wachtel and Wilson, 1983).
Irrespective of the extent to which trapping may be
occurring, the fact that it occurs at all may have particular
significance for models of channel structure. Two particu-
lar physical views of trapping are worth considering. In
one, in accordance with the earlier pictures of Armstrong
(1971) and Hille (1977) to explain blockade of potassium
and sodium channels by quaternary ammonium molecules,
the blocking molecule is completely trapped within the
channel between the permeation barrier and the gate of the
channel. The molecules examined in these studies in
general contained rather bulky hydrophobic domains,
which were imagined to interact with particular regions of
the channel walls. For chlorisondamine, the rather polar
nature of the molecule both in its diquaternary region and
in the tetrachloroindole ring (Fig. 1, inset) suggests that
solubility into the channel protein will be minimal. Thus,
entrapment of chlorisondamine between a channel gate
and permeation barrier would require the presence of a
rather large aqueous space within the closed channel
conformation. Given recent models of internal pore dimen-
sions of at least one energy-minimized conformation of the
acetylcholine channel (Bash, Langridge, and Stroud,
1985), this view is not particularly attractive.
On the other hand, an alternative picture of the underly-
ing physical mechanism is that only a portion of the
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trapped molecule is pinched within the closed channel. The
results of Gurney and Rang (1984) are perhaps most easily
reconciled with this view in that, for bis-trimethylammon-
ium compounds of C4 through C1O, trapping was most
observable for C5 through C8, less so for C9 and CIO, and
not observed for C4. The less pronounced trapping
observed for C9 and C10 may reflect the folding of
molecules of chain length greater than 8 (Coronado and
Miller, 1980), which may place additional constraints on
the ability of the channel to close. Based on evidence that
some molecules as large as C10 can permeate at least some
nicotinic channels (Creese and England, 1970; Lingle,
1983b), it might be expected that inward unblocking could
occur for molecules simply trapped in an aqueous space.
On the other hand, molecules pinched within the closed ion
channel would not be expected to exhibit any recovery in
the absence of reopening of the channel. Given current
views of the pentasymmetric nature of ACh channels
(Brisson and Unwin, 1985) and the possibility of a con-
certed rotation of all subunits in the gating process,
pinching within the closed channel may provide a more
accurate description of drug entrapment. Additionally, the
energy-minimized conformation cited above (Bash, Land-
ridge, and Stroud, 1985) leaves open the possibility that,
although permeation by cations would be impossible, some
space within the core of the channel may be present.
Specific alignment of quaternary residues on a blocking
molecule with negative sites on amphipathic chains of the
ACh channel subunits might in some way stabilize what
might otherwise be an energetically unfavored conforma-
tion.
The main purpose of this paper has been to show the
trapping of drug molecules within an apparently closed-
unliganded conformation of the neuromuscular acetylchol-
ine channel. The structural issues raised above are clearly
beyond the scope of the present study and would require a
systematic investigation with a series of structurally
related agents. As yet, for the vertebrate neuromuscular
junction, an appropriate series of blockers capable of
producing trapping has not been identified. The simple
diquaternary agents that have been investigated on the
ganglionic preparation (Gurney and Rang, 1984) have
complicating agonist and receptor blocking actions at the
endplate (Adams and Sakmann, 1978; Milne and Byrne,
1981). Attempts to fully characterize the trapping phe-
nomenon in other ACh channels have been limited by
particular experimental complications (Gurney and Rang,
1984; Lingle, 1983a). Despite experimental difficulties in
the characterization of trapping, further elucidation of this
phenomenon promises to provide important information
concerning structural features of the closed channel.
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